Disseminated Cutaneous Mycobacterium chelonae Infection in a Patient With Acute Myeloid Leukemia

Open Forum Infectious Diseases
Anna Helena RoukensMark G de Boer

Abstract

We report a case of disseminated cutaneous Mycobacterium chelonae infection in a patient who was treated with chemotherapy for acute myeloid leukemia. We discuss the clinical manifestations, diagnosis, and treatment of this unusual infection in neutropenic patients.

References

Jun 1, 1992·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·P H McWhinneyC C Kibbler
May 25, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Karen Doucette, Jay A Fishman
Feb 6, 2007·American Journal of Respiratory and Critical Care Medicine·David E GriffithUNKNOWN Infectious Disease Society of America
Jul 7, 2009·Biochemical Pharmacology·Anna ZhenchukFreidoun Albertioni
May 27, 2010·Clinical and Experimental Dermatology·J HalpernB B Tan
Jan 1, 2009·BMJ Case Reports·Andrew SmythMichael O'Dwyer
Mar 5, 2013·Pediatrics in Review·Hoover Adger, Shonali Saha
Mar 6, 2013·Seminars in Respiratory and Critical Care Medicine·Jakko van Ingen
May 25, 2013·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Ryan R FalseyMichi M Shinohara
Oct 11, 2013·British Journal of Haematology·Ali Jassem MahdiKhalid Al-Bouri

❮ Previous
Next ❯

Citations

Oct 12, 2016·Microbiology Spectrum·Anne Spichler MoffarahDavid G Armstrong

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsies
biopsy

Related Concepts

Related Feeds

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Related Papers

Cancer Control : Journal of the Moffitt Cancer Center
C L KaneR L Sandin
The Lancet Infectious Diseases
Tang Ngee ShimPhilip W Preston
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
P K SranS M Whitcup
© 2022 Meta ULC. All rights reserved